Xi-Wei Xu
Overview
Explore the profile of Xi-Wei Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song L, Li Y, Wang J, Li N, DU Y, He L, et al.
Zhongguo Dang Dai Er Ke Za Zhi
. 2022 Dec;
24(12):1340-1344.
PMID: 36544416
Objectives: To study the clinical and gastroscopic features of children with cyclic vomiting syndrome. Methods: A retrospective analysis was performed on the medical data of 63 children with cyclic vomiting...
2.
Peng Y, Wang R, Liu Q, Xu X, Wei W, Huang X, et al.
Front Genet
. 2021 Dec;
12:756506.
PMID: 34868231
To investigate the prognostic significance of tumor mutational burden (TMB) combined with specific prognosis-related gene mutations in immunotherapy for recurrent and metastatic head and neck squamous cell carcinoma (r/m HNSCC)....
3.
Peng Y, Liu Q, Lin Y, Peng S, Wang R, Xu X, et al.
Radiat Oncol
. 2021 Oct;
16(1):198.
PMID: 34635145
Background: Second head and neck neuroendocrine carcinoma (NEC) after radical radiotherapy for nasopharyngeal carcinoma (NPC) treatment is rarely reported. The prognosis of second cancer is poor, and our research focuses...
4.
Jin Y, Tang Q, Yao J, Xu X, He W, Wang L, et al.
Transl Oncol
. 2020 Dec;
14(2):100990.
PMID: 33338876
Little is known about the value of adding concurrent chemotherapy (CC) to radiotherapy for stage II nasopharyngeal carcinoma (NPC) with undetectable (0 copies/mL) pretreatment Epstein-Barr Virus (EBV) DNA in the...
5.
Yao J, Qi Z, Liu Z, Jiang G, Xu X, Chen S, et al.
Radiother Oncol
. 2019 May;
137:137-144.
PMID: 31102988
Purpose: To compare clinical features and survival outcomes in patients with ascending type (type A) and descending type (type D) nasopharyngeal carcinoma (NPC) in the intensity-modulated radiotherapy (IMRT) era. Materials...
6.
Sun Y, He Z, Tu R, Wu Y, Jiang E, Xu X
Bioresour Technol
. 2019 May;
286:121390.
PMID: 31078074
In this work, the influence of dry/wet torrefaction with additives on the pyrolysis performance was investigated. The results showed that the content of phenols and ketones (62% and 42%) was...
7.
Wang S, Xu X, Yao J, Peng P, Zhou B, Liu Q, et al.
Transl Oncol
. 2018 Jul;
11(4):1007-1011.
PMID: 29966863
The maximum tolerated dose (MTD) of lobaplatin as a single agent chemotherapy concurrent with intensity-modulated radiotherapy (IMRT) in Asian population with nasopharyngeal carcinoma (NPC) remains unclear. From June 2016 to...
8.
Ma X, Yao K, Xie G, Zheng Y, Wang C, Shang Y, et al.
Chin Med J (Engl)
. 2013 Apr;
126(8):1522-7.
PMID: 23595388
Background: Erythromycin-resistant Streptococcus pneumoniae isolates that causing invasive pneumococcal diseases (IPD) in Chinese children remain uncharacterized. This study aims to identify the resistance genes associated with erythromycin resistance and to...
9.
Guan D, Qiu X, Ding Z, Wang D, Xu X
Zhonghua Yi Xue Za Zhi
. 2012 Sep;
92(28):1984-7.
PMID: 22944275
Objective: To analyze the clinical characteristics and prognosis of pediatric inflammatory bowel disease (IBD) through a long-term follow-up so as to improve the diagnosis and management of IBD in children....
10.
Guo S, Xu X, Dong F
Zhonghua Yi Xue Za Zhi
. 2012 Sep;
92(26):1836-40.
PMID: 22944235
Objective: To explore the risk factors of Clostridium difficile-associated diarrhea (CDAD) in children. Methods: From December 2010 to March 2011, the hospitalized diarrheal patients under 18 years old at Beijing...